{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:21:46Z","timestamp":1791404506631,"version":"4.3.3"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.critrevonc.2023.104235","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T10:54:34Z","timestamp":1705056874000},"page":"104235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Immunotherapy and targeted therapy for cholangiocarcinoma: Artificial intelligence research in imaging"],"prefix":"10.1016","volume":"194","author":[{"given":"Jiong","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7386-7217","authenticated-orcid":false,"given":"Jian","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2023.104235_bib1","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/ncomms5006","article-title":"Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach","volume":"5","author":"Aerts","year":"2014","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.104235_bib2","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1634\/theoncologist.2018-0044","article-title":"Ramucirumab plus pembrolizumab in patients with previously treated advanced or metastatic biliary tract cancer: nonrandomized, open-label, phase i trial (JVDF)","volume":"23","author":"Arkenau","year":"2018","journal-title":"Oncologist"},{"issue":"9","key":"10.1016\/j.critrevonc.2023.104235_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.critrevonc.2023.104235_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.776863","article-title":"Recurrent intrahepatic cholangiocarcinoma - review","volume":"11","author":"Bekki","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104235_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1634\/theoncologist.2011-0386","article-title":"Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping","volume":"17","author":"Borger","year":"2012","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104235_bib6","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104235_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-022-02511-7","article-title":"The VEGF expression associated with prognosis in patients with intrahepatic cholangiocarcinoma: a systematic review and meta-analysis","volume":"20","author":"Cai","year":"2022","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104235_bib8","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-018-0912-x","article-title":"Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence","volume":"18","author":"Chan","year":"2018","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.critrevonc.2023.104235_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215853","article-title":"Immunotherapy of cholangiocarcinoma: Therapeutic strategies and predictive biomarkers","volume":"546","author":"Chen","year":"2022","journal-title":"Cancer Lett."},{"issue":"105","key":"10.1016\/j.critrevonc.2023.104235_bib10","first-page":"20","article-title":"Lymphangiogenic and angiogentic microvessel density in gallbladder carcinoma","volume":"58","author":"Chen","year":"2011","journal-title":"Hepatogastroenterology"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104235_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/life12060829","article-title":"Precision medicine in cholangiocarcinoma: past, present, and future","volume":"12","author":"Cheng","year":"2022","journal-title":"Life"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104235_bib12","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1007\/s00330-020-07250-5","article-title":"Radiomics using CT images for preoperative prediction of futile resection in intrahepatic cholangiocarcinoma","volume":"31","author":"Chu","year":"2021","journal-title":"Eur. Radio."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104235_bib13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","article-title":"Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1-2 trials","volume":"21","author":"Doebele","year":"2020","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104235_bib14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jamcollsurg.2016.05.019","article-title":"Recurrence patterns and disease-free survival after resection of intrahepatic cholangiocarcinoma: preoperative and postoperative prognostic models","volume":"223","author":"Doussot","year":"2016","journal-title":"J. Am. Coll. Surg."},{"key":"10.1016\/j.critrevonc.2023.104235_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1142690","article-title":"Revisiting targeted therapy and immunotherapy for advanced cholangiocarcinoma","volume":"14","author":"Du","year":"2023","journal-title":"Front. Immunol."},{"issue":"Suppl 1","key":"10.1016\/j.critrevonc.2023.104235_bib16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/hep.31410","article-title":"The tumor microenvironment in cholangiocarcinoma progression","volume":"73","author":"Fabris","year":"2021","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.critrevonc.2023.104235_bib17","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s13238-017-0440-4","article-title":"Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers","volume":"9","author":"Feng","year":"2018","journal-title":"Protein Cell"},{"issue":"10","key":"10.1016\/j.critrevonc.2023.104235_bib18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41568-019-0183-z","article-title":"Phagocytosis checkpoints as new targets for cancer immunotherapy","volume":"19","author":"Feng","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2023.104235_bib19","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1007\/s00259-022-05765-1","article-title":"PET\/CT-based radiomics of mass-forming intrahepatic cholangiocarcinoma improves prediction of pathology data and survival","volume":"49","author":"Fiz","year":"2022","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.critrevonc.2023.104235_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-015-0637-z","article-title":"Predictors and patterns of recurrence after curative liver resection in intrahepatic cholangiocarcinoma, for application of postoperative radiotherapy: a retrospective study","volume":"13","author":"Gil","year":"2015","journal-title":"World J. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104235_bib21","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1158\/1078-0432.CCR-17-0432","article-title":"Phase I study of chimeric antigen receptor-modified T cells in patients with EGFR-positive advanced biliary tract cancers","volume":"24","author":"Guo","year":"2018","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104235_bib22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1159\/000518104","article-title":"Immune checkpoint inhibitors: the emerging cornerstone in cholangiocarcinoma therapy?","volume":"10","author":"Gutierrez-Larranaga","year":"2021","journal-title":"Liver Cancer"},{"key":"10.1016\/j.critrevonc.2023.104235_bib23","series-title":"European Conference on Computer Vision","first-page":"630","article-title":"Identity mappings in deep residual networks","author":"He","year":"2016"},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104235_bib24","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S1470-2045(19)30458-9","article-title":"Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF): a multicohort, non-randomised, open-label, phase 1a\/b trial","volume":"20","author":"Herbst","year":"2019","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.104235_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14092208","article-title":"Current perspectives on the surgical management of perihilar cholangiocarcinoma","volume":"14","author":"Hewitt","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2023.104235_bib26","article-title":"Long-term efficacy and safety of larotrectinib in an integrated dataset of patients with TRK fusion cancer","author":"Hong","year":"2021","journal-title":"Wolters Kluwer Health"},{"key":"10.1016\/j.critrevonc.2023.104235_bib27","first-page":"4700","article-title":"Densely connected convolutional networks","author":"Huang","year":"2017","journal-title":"Proc. IEEE Conf. Comput. Vis. Pattern Recognit."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104235_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-018-0870-3","article-title":"Apatinib affect VEGF-mediated cell proliferation, migration, invasion via blocking VEGFR2\/RAF\/MEK\/ERK and PI3K\/AKT pathways in cholangiocarcinoma cell","volume":"18","author":"Huang","year":"2018","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.critrevonc.2023.104235_bib29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejca.2021.06.053","article-title":"Feasibility of magnetic resonance imaging-based radiomics features for preoperative prediction of extrahepatic cholangiocarcinoma stage","volume":"155","author":"Huang","year":"2021","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104235_bib30","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jhep.2020.10.037","article-title":"Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma","volume":"74","author":"Huang","year":"2021","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104235_bib31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1148\/radiol.2018181408","article-title":"Biliary tract cancer at CT: a radiomics-based model to predict lymph node metastasis and survival outcomes","volume":"290","author":"Ji","year":"2019","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104235_bib32","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1007\/s00330-019-06142-7","article-title":"A radiomics approach to predict lymph node metastasis and clinical outcome of intrahepatic cholangiocarcinoma","volume":"29","author":"Ji","year":"2019","journal-title":"Eur. Radio."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104235_bib33","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.21037\/qims-21-1167","article-title":"(18)F-FDG PET\/CT radiomic analysis for classifying and predicting microvascular invasion in hepatocellular carcinoma and intrahepatic cholangiocarcinoma.","volume":"12","author":"Jiang","year":"2022","journal-title":"Quant. Imaging Med Surg."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104235_bib34","doi-asserted-by":"crossref","DOI":"10.1186\/s13321-020-00479-8","article-title":"Could graph neural networks learn better molecular representation for drug discovery? A comparison study of descriptor-based and graph-based models","volume":"13","author":"Jiang","year":"2021","journal-title":"J. Chemin.-."},{"issue":"6230","key":"10.1016\/j.critrevonc.2023.104235_bib35","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.critrevonc.2023.104235_bib36","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S2468-1253(21)00171-0","article-title":"Current and emerging therapies for advanced biliary tract cancers","volume":"6","author":"Kam","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"10391","key":"10.1016\/j.critrevonc.2023.104235_bib37","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0140-6736(23)00727-4","article-title":"Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley","year":"2023","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104235_bib38","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jamaoncol.2020.0930","article-title":"A phase 2 multi-institutional study of nivolumab for patients with advanced refractory biliary tract cancer","volume":"6","author":"Kim","year":"2020","journal-title":"JAMA Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.104235_bib39","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s11605-013-2286-2","article-title":"Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer","volume":"17","author":"Kobayashi","year":"2013","journal-title":"J. Gastrointest. Surg.: Off. J. Soc. Surg. Aliment. Trac."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104235_bib40","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-5391-0","article-title":"Molecular pathogenesis of cholangiocarcinoma","volume":"19","author":"Labib","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104235_bib41","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jhep.2020.03.007","article-title":"Molecular targeted therapies: ready for \"prime time\" in biliary tract cancer","volume":"73","author":"Lamarca","year":"2020","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104235_bib42","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","article-title":"Radiomics: extracting more information from medical images using advanced feature analysis","volume":"48","author":"Lambin","year":"2012","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104235_bib43","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/jum.15833","article-title":"Preoperative survival prediction in intrahepatic cholangiocarcinoma using an ultrasound-based radiographic-radiomics signature","volume":"41","author":"Li","year":"2022","journal-title":"J. Ultrasound Med"},{"key":"10.1016\/j.critrevonc.2023.104235_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00360","article-title":"Novel nomogram for preoperative prediction of early recurrence in intrahepatic cholangiocarcinoma","volume":"8","author":"Liang","year":"2018","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104235_bib45","doi-asserted-by":"crossref","DOI":"10.1186\/s13244-021-01147-7","article-title":"Multimodal molecular imaging evaluation for early diagnosis and prognosis of cholangiocarcinoma","volume":"13","author":"Liu","year":"2022","journal-title":"Insights Imaging"},{"issue":"10","key":"10.1016\/j.critrevonc.2023.104235_bib46","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1172\/JCI137110","article-title":"Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma","volume":"130","author":"Loeuillard","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104235_bib47","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10916-008-9203-3","article-title":"Cholangiocarcinoma\u2014an automated preliminary detection system using MLP","volume":"33","author":"Logeswaran","year":"2009","journal-title":"J. Med. Syst."},{"key":"10.1016\/j.critrevonc.2023.104235_bib48","doi-asserted-by":"crossref","unstructured":"Lwin, Z., Gomez-Roca, C., Saada-Bouzid, E., Yanez, E., Munoz, F., Im, S., Castanon, E., Senellart, H., Graham, D., Voss, M., 2020. LEAP-005: Phase II study of lenvatinib (len) plus pembrolizumab (pembro) in patients (pts) with previously treated advanced solid tumours.","DOI":"10.1016\/j.annonc.2020.08.2271"},{"issue":"30","key":"10.1016\/j.critrevonc.2023.104235_bib49","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.2217\/fon-2020-0299","article-title":"Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions\/translocations: the PROOF 301 trial","volume":"16","author":"Makawita","year":"2020","journal-title":"Future Oncol."},{"key":"10.1016\/j.critrevonc.2023.104235_bib50","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.omtn.2019.04.019","article-title":"Meta-4mCpred: a sequence-based meta-predictor for accurate DNA 4mC site prediction using effective feature representation","volume":"16","author":"Manavalan","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104235_bib51","article-title":"New insights on the role of vascular endothelial growth factor in biliary pathophysiology","volume":"3","author":"Mariotti","year":"2021","journal-title":"JHEP Rep."},{"key":"10.1016\/j.critrevonc.2023.104235_bib52","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jss.2018.01.024","article-title":"A nomogram to predict lymph node metastasis before resection in intrahepatic cholangiocarcinoma","volume":"226","author":"Meng","year":"2018","journal-title":"J. Surg. Res"},{"key":"10.1016\/j.critrevonc.2023.104235_bib53","series-title":"2016 fourth international conference on 3D vision (3DV)","first-page":"565","article-title":"V-net: fully convolutional neural networks for volumetric medical image segmentation","author":"Milletari","year":"2016"},{"issue":"79","key":"10.1016\/j.critrevonc.2023.104235_bib54","doi-asserted-by":"crossref","first-page":"34857","DOI":"10.18632\/oncotarget.26207","article-title":"Bevacizumab as a chemoprotectant: reducing oxaliplatin induced hepatic sinusoidal injury","volume":"9","author":"Mizrahi","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2023.104235_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.artmed.2020.101878","article-title":"Deep learning in generating radiology reports: a survey","volume":"106","author":"Monshi","year":"2020","journal-title":"Artif. Intell. Med"},{"key":"10.1016\/j.critrevonc.2023.104235_bib56","article-title":"Immune escape: a critical hallmark in solid tumors","volume":"258","author":"Mortezaee","year":"2020","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104235_bib57","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1007\/s00330-020-06795-9","article-title":"Radiomics of cholangiocarcinoma on pretreatment CT can identify patients who would best respond to radioembolisation","volume":"30","author":"Mosconi","year":"2020","journal-title":"Eur. Radio."},{"issue":"18","key":"10.1016\/j.critrevonc.2023.104235_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184362","article-title":"Improvement of epitope prediction using peptide sequence descriptors and machine learning","volume":"20","author":"Munteanu","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104235_bib59","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1002\/jcp.27425","article-title":"Tumor microenvironment: Interactions and therapy","volume":"234","author":"Najafi","year":"2019","journal-title":"J. Cell Physiol."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.104235_bib60","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat. Genet"},{"key":"10.1016\/j.critrevonc.2023.104235_bib61","doi-asserted-by":"crossref","first-page":"S1462","DOI":"10.1016\/j.annonc.2022.10.114","article-title":"78P Updated overall survival (OS) from the phase III TOPAZ-1 study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin (+ GC) in patients (pts) with advanced biliary tract cancer (BTC)","volume":"33","author":"Oh","year":"2022","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104235_bib62","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S2468-1253(22)00043-7","article-title":"Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study","volume":"7","author":"Oh","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104235_bib63","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1700935","article-title":"Extensive arsenic contamination in high-pH unconfined aquifers in the Indus Valley","volume":"3","author":"Podgorski","year":"2017","journal-title":"Sci. Adv."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.104235_bib64","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/cgt.2015.60","article-title":"Recombinant vaccinia virus GLV-1h68 is a promising oncolytic vector in the treatment of cholangiocarcinoma","volume":"22","author":"Pugalenthi","year":"2015","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.critrevonc.2023.104235_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.838701","article-title":"A multi-parametric radiomics nomogram for preoperative prediction of microvascular invasion status in intrahepatic cholangiocarcinoma","volume":"12","author":"Qian","year":"2022","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104235_bib66","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/liv.14763","article-title":"Machine-learning radiomics to predict early recurrence in perihilar cholangiocarcinoma after curative resection","volume":"41","author":"Qin","year":"2021","journal-title":"Liver Int."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104235_bib67","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/13543784.2021.1881479","article-title":"Angiogenesis in biliary tract cancer: targeting and therapeutic potential","volume":"30","author":"Rimini","year":"2021","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104235_bib68","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma - evolving concepts and therapeutic strategies","volume":"15","author":"Rizvi","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104235_bib69","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/13543784.2021.1897102","article-title":"Durvalumab: an investigational anti-PD-L1 antibody for the treatment of biliary tract cancer","volume":"30","author":"Rizzo","year":"2021","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.critrevonc.2023.104235_bib70","series-title":"U-Net: Convolutional Networks for Biomedical Image Segmentation","first-page":"234","author":"Ronneberger","year":"2015"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104235_bib71","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac450","article-title":"EMLI-ICC: an ensemble machine learning-based integration algorithm for metastasis prediction and risk stratification in intrahepatic cholangiocarcinoma","volume":"23","author":"Ruan","year":"2022","journal-title":"Brief. Bioinform."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104235_bib72","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1358\/dot.2022.58.7.3408813","article-title":"Infigratinib for cholangiocarcinoma","volume":"58","author":"Sadeghi","year":"2022","journal-title":"Drugs Today"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104235_bib73","doi-asserted-by":"crossref","first-page":"158","DOI":"10.32074\/1591-951X-252","article-title":"Cholangiocarcinoma","volume":"113","author":"Sarcognato","year":"2021","journal-title":"Pathologica"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104235_bib74","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1148\/radiol.2019190938","article-title":"Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment","volume":"293","author":"Schelb","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.critrevonc.2023.104235_bib75","doi-asserted-by":"crossref","unstructured":"Schenker, M., Burotto, M., Richardet, M., Ciuleanu, T., Goncalves, A., Steeghs, N., Schoffski, P., Ascierto, P.A., Maio, M., Lugowska, I., 2022. CheckMate 848: a randomized, open-label, phase 2 study of nivolumab in combination with ipilimumab or nivolumab monotherapy in patients with advanced or metastatic solid tumors of high tumor mutational burden, CANCER RESEARCH. AMER ASSOC CANCER RESEARCH 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA \u2026.","DOI":"10.1158\/1538-7445.AM2022-CT022"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104235_bib76","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1097\/SLE.0000000000000502","article-title":"Artificial Neural Networking Model for the Prediction of Early Occlusion of Bilateral Plastic Stent Placement for Inoperable Hilar Cholangiocarcinoma","volume":"28","author":"Shao","year":"2018","journal-title":"Surg. Laparosc. Endosc. Percutan Tech."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104235_bib77","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/gerona\/glaa138","article-title":"Machine Learning in Aging: An Example of Developing Prediction Models for Serious Fall Injury in Older Adults","volume":"76","author":"Speiser","year":"2021","journal-title":"J. Gerontol. Ser. A, Biol. Sci. Med. Sci."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.104235_bib78","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S1470-2045(20)30321-1","article-title":"Dabrafenib plus trametinib in patients with BRAF(V600E)-mutated biliary tract cancer (ROAR): a phase 2, open-label, single-arm, multicentre basket trial","volume":"21","author":"Subbiah","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2023.104235_bib79","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ymeth.2021.04.005","article-title":"Diagnosis of cholangiocarcinoma from microscopic hyperspectral pathological dataset by deep convolution neural networks","volume":"202","author":"Sun","year":"2022","journal-title":"Methods"},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104235_bib80","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.ymthe.2022.05.003","article-title":"LAG-3xPD-L1 bispecific antibody potentiates antitumor responses of T cells through dendritic cell activation","volume":"30","author":"Sung","year":"2022","journal-title":"Mol. Ther.: J. Am. Soc. Gene Ther."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.104235_bib81","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/pin.12440","article-title":"Role of tumor-associated macrophages in human malignancies: friend or foe?","volume":"66","author":"Takeya","year":"2016","journal-title":"Pathol. Int"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104235_bib82","first-page":"525","article-title":"Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1\/2, thrombospondin-1 and clinicopathological significance","volume":"15","author":"Tang","year":"2006","journal-title":"Oncol. Rep."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.104235_bib83","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s00535-008-2255-9","article-title":"Microvessel density correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma","volume":"43","author":"Thelen","year":"2008","journal-title":"J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104235_bib84","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ajg.2009.674","article-title":"Tumor-associated angiogenesis and lymphangiogenesis correlate with progression of intrahepatic cholangiocarcinoma","volume":"105","author":"Thelen","year":"2010","journal-title":"Am. J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.104235_bib85","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jamasurg.2020.1973","article-title":"Very early recurrence after liver resection for intrahepatic cholangiocarcinoma: considering alternative treatment approaches","volume":"155","author":"Tsilimigras","year":"2020","journal-title":"JAMA Surg."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104235_bib86","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3390\/cancers12061644","article-title":"Pilot multi-omic analysis of human bile from benign and malignant biliary strictures: a machine-learning approach","volume":"12","author":"Urman","year":"2020","journal-title":"Cancers"},{"issue":"18","key":"10.1016\/j.critrevonc.2023.104235_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15184446","article-title":"Targetable molecular alterations in the treatment of biliary tract cancers: an overview of the available treatments","volume":"15","author":"Valery","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2023.104235_bib88","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1200\/EDBK_156572","article-title":"Basic overview of current immunotherapy approaches in cancer","author":"Velcheti","year":"2016","journal-title":"Am. Soc. Clin. Oncol. Educ. Book 35"},{"issue":"21","key":"10.1016\/j.critrevonc.2023.104235_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10214901","article-title":"Emerging therapies for advanced cholangiocarcinoma: an updated literature review","volume":"10","author":"Vignone","year":"2021","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104235_bib90","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","article-title":"Biliary tract cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Vogel","year":"2023","journal-title":"Ann. Oncol.: Off. J. Eur. Soc. Med. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104235_bib91","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.4075","article-title":"Regional subgroup analysis of the phase 3 TOPAZ-1 study of durvalumab (D) plus gemcitabine and cisplatin (GC) in advanced biliary tract cancer (BTC)","author":"Vogel","year":"2022","journal-title":"Am. Soc. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104235_bib92","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1148\/radiol.2020190925","article-title":"Development and validation of a multitask deep learning model for severity grading of hip osteoarthritis features on radiographs","volume":"295","author":"von Schacky","year":"2020","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104235_bib93","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-12604-8","article-title":"CT-based deep learning enables early postoperative recurrence prediction for intrahepatic cholangiocarcinoma","volume":"12","author":"Wakiya","year":"2022","journal-title":"Sci. Rep."},{"issue":"49","key":"10.1016\/j.critrevonc.2023.104235_bib94","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013372","article-title":"Apatinib for treating advanced intrahepatic cholangiocarcinoma after failed chemotherapy: a case report and literature review","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.critrevonc.2023.104235_bib95","doi-asserted-by":"crossref","first-page":"85271","DOI":"10.1109\/ACCESS.2020.2992627","article-title":"SCCNN: a diagnosis method for hepatocellular carcinoma and intrahepatic cholangiocarcinoma based on siamese cross contrast neural network","volume":"8","author":"Wang","year":"2020","journal-title":"IEEE Access"},{"key":"10.1016\/j.critrevonc.2023.104235_bib96","article-title":"Deep learning radiomics to predict regional lymph node staging for hilar cholangiocarcinoma","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104235_bib97","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/bjs\/znac098","article-title":"Prognostic impact of perineural invasion in intrahepatic cholangiocarcinoma: multicentre study","volume":"109","author":"Wei","year":"2022","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.critrevonc.2023.104235_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.774117","article-title":"Radiomics analysis of contrast-enhanced CT for the preoperative prediction of microvascular invasion in mass-forming intrahepatic cholangiocarcinoma","volume":"11","author":"Xiang","year":"2021","journal-title":"Front. Oncol."},{"issue":"18","key":"10.1016\/j.critrevonc.2023.104235_bib99","doi-asserted-by":"crossref","first-page":"5374","DOI":"10.7150\/thno.34149","article-title":"A radiomics approach based on support vector machine using MR images for preoperative lymph node status evaluation in intrahepatic cholangiocarcinoma","volume":"9","author":"Xu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2023.104235_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2019.11.036","article-title":"Radiomics model of magnetic resonance imaging for predicting pathological grading and lymph node metastases of extrahepatic cholangiocarcinoma","volume":"470","author":"Yang","year":"2020","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104235_bib101","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/sj.bjc.6604129","article-title":"Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma","volume":"98","author":"Yoshikawa","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2023.104235_bib102","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211039952","article-title":"Application of immune checkpoint inhibitors in the treatment of cholangiocarcinoma","volume":"20","author":"Zeng","year":"2021","journal-title":"Technol. Cancer Res Treat."},{"key":"10.1016\/j.critrevonc.2023.104235_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.900478","article-title":"CT-based radiomics analysis for noninvasive prediction of perineural invasion of perihilar cholangiocarcinoma","volume":"12","author":"Zhan","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104235_bib104","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000910","article-title":"Machine learning: an approach to preoperatively predict PD-1\/PD-L1 expression and outcome in intrahepatic cholangiocarcinoma using MRI biomarkers","volume":"5","author":"Zhang","year":"2020","journal-title":"ESMO Open"},{"issue":"11","key":"10.1016\/j.critrevonc.2023.104235_bib105","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1245\/s10434-022-12028-8","article-title":"Radiomics-based preoperative prediction of lymph node metastasis in intrahepatic cholangiocarcinoma using contrast-enhanced computed tomography","volume":"29","author":"Zhang","year":"2022","journal-title":"Ann. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104235_bib106","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/bjs.10676","article-title":"Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent","volume":"105","author":"Zhang","year":"2018","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.critrevonc.2023.104235_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.109631","article-title":"Development and validation of preoperative magnetic resonance imaging-based survival predictive nomograms for patients with perihilar cholangiocarcinoma after radical resection: a pilot study","volume":"138","author":"Zhao","year":"2021","journal-title":"Eur. J. Radiol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104235_bib108","doi-asserted-by":"crossref","DOI":"10.1186\/s40644-019-0234-4","article-title":"Prediction for early recurrence of intrahepatic mass-forming cholangiocarcinoma: quantitative magnetic resonance imaging combined with prognostic immunohistochemical markers","volume":"19","author":"Zhao","year":"2019","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.critrevonc.2023.104235_bib109","first-page":"720","article-title":"Craniomaxillofacial bony structures segmentation from MRI with deep-supervision adversarial learning","volume":"11073","author":"Zhao","year":"2018","journal-title":"Med Image Comput. Comput. Assist Inter."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104235_bib110","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jvir.2019.03.001","article-title":"Risk prediction for early biliary infection after percutaneous transhepatic biliary stent placement in malignant biliary obstruction","volume":"30","author":"Zhou","year":"2019","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.104235_bib111","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.1007\/s00330-021-07793-1","article-title":"Radiomics signature on dynamic contrast-enhanced MR images: a potential imaging biomarker for prediction of microvascular invasion in mass-forming intrahepatic cholangiocarcinoma","volume":"31","author":"Zhou","year":"2021","journal-title":"Eur. Radio."},{"key":"10.1016\/j.critrevonc.2023.104235_bib112","first-page":"232","article-title":"Context-driven concept annotation in radiology reports: anatomical phrase labeling","volume":"2019","author":"Zhu","year":"2019","journal-title":"AMIA Jt Summits Transl. Sci. Proc."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823003232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823003232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:55:06Z","timestamp":1760903706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842823003232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":112,"alternative-id":["S1040842823003232"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.104235","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunotherapy and targeted therapy for cholangiocarcinoma: Artificial intelligence research in imaging","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.104235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104235"}}